Last reviewed · How we verify
Radiosensitive therapy
At a glance
| Generic name | Radiosensitive therapy |
|---|---|
| Also known as | Chemotherapy |
| Sponsor | Istituto Clinico Humanitas |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Precision Radiation Treatment for Epilepsy (PRECISION) (NA)
- A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer (PHASE3)
- Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma (NA)
- A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection (NA)
- Preoperative Radiotherapy and Local Excision in Rectal Cancer (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Radiosensitive therapy CI brief — competitive landscape report
- Radiosensitive therapy updates RSS · CI watch RSS
- Istituto Clinico Humanitas portfolio CI